A -year-old man with a history of generalized tonic-clonic seizures is being managed in the neurology clinic with oral phenytoin. His seizure diary indicates incomplete control. His medication history and laboratory results show the following steady-state serum phenytoin concentrations based on his daily maintenance dose:
- At a dose of , his steady-state concentration was .
- His dose was then increased to . After weeks of adherence, his steady-state concentration was .
His seizures are less frequent but still occasionally occur, and he reports no symptoms of toxicity. The neurologist decides to target a steady-state serum concentration of to optimize efficacy. Phenytoin exhibits capacity-limited (Michaelis-Menten) elimination kinetics.
Assuming bioavailability and that no salt factor adjustments are needed (), what is the required new daily maintenance dose in to achieve this exact target steady-state concentration?
Answer: 450 mg/day